| [1] |
江涛,毛庆,王翔. p53靶向小分子RITA联合替莫唑胺对胶质瘤细胞体外生长的影响[J]. 海南医学院学报, 2017,23(11):1459-1462.
|
| [2] |
王鹏,侯崇显,詹升全,等. 靶向沉默Wip1基因协同替莫唑胺抑制脑胶质瘤细胞增殖的作用[J]. 临床神经外科杂志, 2015,12(1):1-4.
|
| [3] |
PAZHOUHI M, SARIRI R, KHAZAEI M R, et al.Synergistic effect of temozolomide and thymoquinone on human glioblastoma multiforme cell line (U87MG)[J]. J Cancer Res Ther, 2018,14(5):1023-1028.
|
| [4] |
XU G, LI W, ZHANG P, et al.Silencing of carcinoembryonic antigen-related cell adhesion molecule 1 inhibits proliferation and induces apoptosis in human glioma SHG44 cells[J]. Xi bao yu fen zi mian yi xue za zhi, 2015,31(1):23-26, 31.
|
| [5] |
FERREIRA J, RAMOS A A, ALMEIDA T, et al.Drug resistance in glioblastoma and cytotoxicity of seaweed compounds, alone and in combination with anticancer drugs: A mini review[J]. Phytomedicine, 2018,48(9):84-93.
|
| [6] |
NGUYEN H S, SHABANI S, AWAD A J, et al.Molecular markers of therapy-resistant glioblastoma and potential strategy to combat resistance[J]. Int J Mol Sci, 2018,19(6):1765.
|
| [7] |
CHIO C C, TAI Y T, MOHANRAJ M, et al.Honokiol enhances temozolomide-induced apoptotic insults to malignant glioma cells via an intrinsic mitochondrion-dependent pathway[J]. Phytomedicine, 2018,49(10):41-51.
|
| [8] |
PAZHOUHI M, SARIRI R, KHAZAEI M R, et al.Synergistic effect of temozolomide and thymoquinone on human glioblastoma multiforme cell line (U87MG)[J]. J Cancer Res Ther, 2018,14(5):1023-1028.
|
| [9] |
LU J, LI Q, CAI L, et al.RBM17 controls apoptosis and proliferation to promote Glioma progression[J]. Biochem Biophys Res Commun, 2018,505(1):20-28.
|
| [10] |
STEVERDING D, RUSHWORTH S A.Front-line glioblastoma chemotherapeutic temozolomide is toxic to Trypanosoma brucei and potently enhances melarsoprol and eflornithine[J]. Experimental parasitology, 2017,178(4):45-50.
|
| [11] |
杨沛,颜伟,张伟,等. 应用脑胶质瘤基因表达谱分析脑胶质瘤恶性进展相关基因[J]. 中华医学杂志, 2013,93(1):5-7.
|
| [12] |
许刚柱, 张鹏, 李文, 等. siRNA沉默CEACAM1基因对人胶质瘤SHG44细胞生物学行为的作用[J]. 山西医科大学学报, 2014,45(10):920-925.
|
| [13] |
STEPANENKO A A, KAVSAN V M.Karyotypically distinct U251, U373, and SNB19 glioma cell lines are of the same origin but have different drug treatment sensitivities[J]. Gene, 2014,540(2):263-265.
|